Metabolism 5.2 Oxidative Stress and Antioxidant Defence Mechanisms

Oxidative Stress

  • Definition: Condition where generation of reactive oxygen species (ROS) and reactive nitrogen species (RNS) exceeds the body’s ability to protect itself.

    • Consequences include increased oxidative damage to macromolecules (proteins, lipids, DNA) leading to cell/tissue damage.

    • Imbalance between oxidants and antioxidants drives cellular injury and disease.

Redox Reactions (Foundational Concept)

  • Redox reactions: Involve simultaneous oxidation and reduction.

    • OIL RIG: Oxidation Is Loss, Reduction Is Gain of electrons.

    • Oxidizing agent (oxidant): Oxidises another substance and becomes reduced.

    • Reducing agent (reductant): Reduces another substance and is oxidised.

    • Practical implication: In biology, redox couples regulate signaling and oxidative damage.

Reactive Oxygen and Nitrogen Species (ROS & RNS)

  • Reactive Oxygen Species (ROS): Includes superoxide ( ext{O}2^{ullet-}), hydrogen peroxide (extH</em>2extO2ext{H}</em>2 ext{O}*2), hydroxyl radical ( ext{OH}^{ullet}).

  • Reactive Nitrogen Species (RNS): Includes nitric oxide ( ext{NO}^{ullet}) and peroxynitrite (extONOOext{ONOO}^-).

  • Free radical definition: Atom/molecule with one or more unpaired electrons; highly reactive ( ext{OH}^{ullet}).

    • Readily diffusible and react with many cellular targets.

  • Key interaction: Superoxide reacts with nitric oxide to form peroxynitrite (extONOOext{ONOO}^-), a powerful oxidant.

Formation of ROS in Cells

  • Electron Transport Chain (ETC) as a source: Electrons occasionally escape, reducing extO<em>2ext{O}<em>2 to form superoxide ( ext{O}2^{ullet-}).

    • Superoxide-derived ROS give rise to other ROS.

  • Other endogenous sources: Peroxidases, nitric oxide synthases, NADPH oxidases, xanthine oxidase.

  • Exogenous sources: Radiation, pollutants, drugs (e.g., paracetamol), toxins.

Key ROS/RNS Reactions and Consequences

  • Superoxide to hydrogen peroxide: Superoxide dismutase (SOD) converts ext{O}2^{ullet-} to extH</em>2extO2ext{H}</em>2 ext{O}_2.

    • Reaction: 2 O<em>2+2 H+H</em>2O<em>2+O</em>22 \ \mathrm{O}<em>2^{\bullet-} + 2 \ \mathrm{H}^+ \rightarrow \mathrm{H}</em>2\mathrm{O}<em>2 + \mathrm{O}</em>2

  • Hydroxyl radical formation (Fenton chemistry): Fe2++H<em>2O</em>2Fe3++OH+OH\mathrm{Fe}^{2+} + \mathrm{H}<em>2\mathrm{O}</em>2 \rightarrow \mathrm{Fe}^{3+} + \mathrm{OH}^- + \mathrm{OH}^{\bullet}.

  • Peroxynitrite formation: NO+O2ONOO\mathrm{NO}^{\bullet} + \mathrm{O}_2^{\bullet-} \rightarrow \mathrm{ONOO}^-.

  • Nitric oxide synthases (NOS): Generate ext{NO}^{ullet} from arginine (iNOS, eNOS, nNOS).

Nitric Oxide Synthase (NOS) and Nitric Oxide (NO)

  • NOS catalysis: Oxidation of arginine to citrulline and ext{NO}^{ullet}.

  • NOS cofactors: FMN, FAD, heme, tetrahydrobiopterin (BH4).

  • NO interactions: Reacts readily with extO2ext{O}*2, metals, nucleic acids, and proteins.

  • Low NO levels: Can inhibit cytochrome oxidase and support cell survival.

  • High NO levels: Damage mitochondrial complexes, cause post-translational modifications (nitrosylation), and lead to cell death.

  • Roles of NOS isoforms:

    • iNOS: Inducible, high ext{NO}^{ullet} production in phagocytes for antimicrobial effects.

    • eNOS: Endothelial signaling; vasodilation.

    • nNOS: Neuronal signaling.

DNA Damage from ROS

  • Two main ROS-induced DNA damages:

    • Base damage: Leading to mispairing and mutations (oxidized bases).

    • Sugar/phosphodiester damage: Causing strand breaks during repair.

  • 8-Oxo-2′-deoxyguanosine (8-oxo-dG): Marker for oxidative DNA damage.

    • Accumulation correlates with cancer risk when repair is compromised.

    • Used as an oxidative damage biomarker.

DNA Damage from ROS (Overview of Consequences)

  • Consequences: ROS interactions with DNA drive mutations and genomic instability.

    • Failure to repair ROS-induced DNA lesions increases cancer risk.

Protein Damage from ROS

  • ROS attack on proteins leads to:

    • Backbone fragmentation.

    • Side-chain modifications: carbonylation, hydroxylation.

    • Formation of protein cross-links (e.g., di-tyrosine dimers).

    • Loss or gain of function due to structural changes (e.g., disulfide bonds in insulin).

Lipid Peroxidation and Membrane Damage

  • Mechanism: Unsaturated lipids react with ROS to form lipid peroxides.

  • Consequences: Damages cell membranes, alters fluidity, and generates reactive aldehydes.

    • Implicated in early cardiovascular disease processes.

Nitric Oxide Synthase (NOS)–NO in Cells (Detailed)

  • NOS reaction: Arginine+ O<em>2+NADPHCitrulline+NO+NADP++H</em>2O\text{Arginine} + \ \mathrm{O}<em>2 + \mathrm{NADPH} \rightarrow \text{Citrulline} + \mathrm{NO}^{\bullet} + \mathrm{NADP}^+ + \mathrm{H}</em>2\mathrm{O}.

  • NO interactions: Broaden signaling, but high NO can damage mitochondria and proteins.

    • Can participate in nitrosylation of thiol groups and other post-translational modifications.

Cellular Defence Mechanisms Against ROS/RNS

  • Major defenses: Enzymatic and non-enzymatic systems to maintain non-damaging ROS/RNS levels.

  • Non-enzymatic pool: Glutathione (GSH) in reduced (GSH) and oxidized (GSSG) forms.

  • Key enzymes:

    • Glutathione peroxidase (GPx): Reduces extH<em>2extO</em>2ext{H}<em>2 ext{O}</em>2 and organic peroxides using GSH.

    • Glutathione reductase (GR): Regenerates GSH from GSSG using NADPH.

    • NADPH oxidase (NOX): Generates ROS for signaling/defense; tightly regulated.

    • Nicotinamide adenine dinucleotide phosphate (NADPH): Reducing power for GSSG-to-GSH regeneration.

  • Pentose phosphate pathway (PPP): Generates NADPH, vital for maintaining GSH:GSSG ratio.

  • GSH regeneration cycle: GSSG+NADPH+H+2GSH+NADP+\text{GSSG} + \mathrm{NADPH} + \mathrm{H}^+ \rightarrow 2\text{GSH} + \mathrm{NADP}^+.

    • GSH donates electrons (via cysteine thiol) to reduce oxidants, becoming GSSG.

    • GR regenerates GSH from GSSG using NADPH.

    • Maintains cellular redox homeostasis and detoxifies peroxides.

Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency

  • Definition: X-linked recessive enzyme deficiency, affects RBC protection against oxidative stress.

    • Common in African, Mediterranean, and Middle Eastern populations (\sim400 million people).

    • Provides some protection against malaria.

  • Clinical presentation:

    • Most individuals asymptomatic.

    • Occasional severe haemolytic anaemia during oxidative stress (haemolytic crisis).

  • Pathophysiology:

    • G6PD deficiency lowers PPP NADPH production.

    • Reduced NADPH limits regeneration of GSH from GSSG.

    • Decreased GSH leads to vulnerability to ROS, causing damage.

  • Red cell consequences in oxidative crises: Heinz bodies, haemolysis.

G6PD Deficiency – Mechanistic View

  • Pathway disruption: \downarrowG6PDH \rightarrow \downarrowNADPH \rightarrow \downarrowGSH reduction.

  • Consequences:

    • Oxidative stress–related damage to lipids, proteins, and DNA.

    • Heinz bodies formation and hemolytic anemia if exposed to oxidants.

    • Higher sensitivity to infection, certain drugs, and fava beans as triggers.

Heinz Bodies and Related RBC Pathology (Context of G6PD)

  • Heinz bodies: Dark inclusions due to precipitated hemoglobin (Hb) inside RBCs.

    • Bind to cell membrane, increasing rigidity and causing mechanical stress.

    • Spleen removes Heinz bodies, leading to blister cells.

    • Clinical sign of G6PD deficiency-related hemolysis.

Galactosaemia and Related Pathways (Oxygen/NADPH Context)

  • Galactosaemia: Defects in galactose metabolism enzymes (Galactokinase, Uridyltransferase, UDP-galactose epimerase).

    • Consequence: Accumulation of galactitol via aldose reductase (polyol pathway) consuming NADPH.

    • NADPH depletion: Compromises antioxidant defenses, contributing to cataracts, hepatic, and renal complications.

    • Metabolic flow: Dietary lactose <br>ightarrow<br>ightarrow galactose + glucose; galactose involved in polyol pathway.

Oxygen Toxicity (Clinical Implications of Excess Oxygen)

  • Mechanism: Excessive oxygen exposure increases ROS formation.

  • Detrimental effects: Damage to bronchioles/alveoli, retina, and other tissues.

    • Occurs in both infants and adults under prolonged respiratory support.

Diseases and Conditions Linked to Free Radical Damage (Broad Overview)

  • Multifactorial associations: ROS/RNS contribute but are not sole causes.

  • Linked conditions include:

    • Atheroma (atherosclerosis).

    • Cancers.

    • Autoimmune and inflammatory diseases (e.g., rheumatoid arthritis).

    • Neurodegenerative diseases (including dementia).

    • Cataracts and macular degeneration.

    • Aging processes.

Progression of Atheroma (Conceptual Model)

  • Progression: Healthy artery ightarrowightarrow atheroma plaque formation ightarrowightarrow plaque rupture ightarrowightarrow thrombosis ightarrowightarrow impaired blood flow.

    • Oxidative stress contributes to lipid oxidation and plaque instability.

Cellular Defences – Antioxidants (Non-enzymatic Defenders)

  • Vitamin E (α\alpha-tocopherol): Lipid-soluble antioxidant; protects against lipid peroxidation.

  • Vitamin C (ascorbic acid): Water-soluble antioxidant; regenerates reduced Vitamin E.

    • Vitamin E scavenges lipids and becomes oxidized; Vitamin C regenerates reduced Vitamin E.

  • Other non-enzymatic antioxidants: Carotenoids, flavonoids, selenium (cofactor for GPx), uric acid, melatonin, zinc.

  • General mechanism: Free radical scavengers donate a hydrogen atom (and its electron) to neutralize free radicals.

Antioxidant Enzyme Systems (Key Players)

  • SOD: Converts superoxide to hydrogen peroxide.

  • CAT (catalase) and GPX (glutathione peroxidase): Convert hydrogen peroxide to water.

  • GSR (glutathione reductase): Regenerates GSH from GSSG using NADPH.

  • GST (glutathione-S-transferase): Involved in detoxification pathways.

  • Metal cofactors: Mn, Cu, Zn.

Antioxidant Foods and Supplements – Practical Perspective

  • Dietary antioxidants: Vitamins A, C, E; minerals Mn, Se, Zn; carotenoids; plant-based foods (fruits, vegetables, coffee, dark chocolate).

    • Caveat: Not miracle cures; claims should be interpreted cautiously.

  • Supplements: Can be helpful but not a panacea; effectiveness varies.

Respiratory Burst (Phagocytic Defense) and CGD

  • Respiratory Burst: Phagocytes (e.g., neutrophils) rapidly release ROS/H<em>2O</em>2\text{H}<em>2\text{O}</em>2 to destroy invading bacteria.

  • Chronic Granulomatous Disease (CGD): Genetic defects in the NADPH oxidase complex.

    • Leads to increased susceptibility to infections (atypical infections, pneumonia, abscesses, cellulitis).

    • Respiratory burst is a controlled ROS burst for immunity; defects heighten infection risk.

Summary of Key Concepts (Cohesive View)

  • Oxidative stress: ROS/RNS production exceeding defenses, causing damage to DNA, proteins, lipids.

  • ROS/RNS formation: Mitochondrial leakage, NO synthases, NADPH oxidases, other sources.

  • ROS damages: DNA base/sugar damage (e.g., 8-oxo-dG), protein oxidation, lipid peroxidation, contributing to various diseases.

  • Antioxidant defenses: Enzymatic systems (SOD, CAT, GPX, GR, GST) and non-enzymatic antioxidants (Vitamins E/C, carotenoids, GSH/GSSG cycle, NADPH via PPP).

  • NADPH central role: Regenerating reduced antioxidants (GSH) and enzymatic defenses; PPP is primary source.

  • G6PD deficiency: Limits NADPH supply, compromising oxidative defense, leading to hemolysis and Heinz bodies.

  • NOS/NO biology: Dual roles ranging from physiological signaling to cytotoxicity at high levels or with ONOO^-.

  • Oxygen toxicity: Excessive ROS from prolonged high oxygen exposure clinically.

  • Pathophysiological links: Atheroma progression, cancer, neurodegeneration.

  • Clinical implications: Cautious use of oxidant drugs, awareness of G6PD status (e.g., with nitrofurantoin, primaquine), judicious oxygen therapy.

Notable Ancillary Content (contextual and non-core items from the transcript)

  • Product advertisement: Mothballs, medication panel (Page 23).

  • Educational inserts: Oxygen toxicity in clinical care (Page 26–27).

  • Galactosaemia section: Metabolic pathway details and NADPH consumption via aldose reductase (Page 23–25).

  • Summary citation list: References to antioxidant studies (Page 35).

Connections to Foundational Principles and Real-World Relevance

  • Redox biology: Unifying framework for understanding aging, cancer, neurodegeneration, cardiovascular disease.

  • Balance: Between ROS production and antioxidant capacity is a dynamic determinant of cell fate.

  • Real-world relevance: Clinical strategies (CGD diagnosis/management, NADPH-dependent antioxidant support, oxygen therapy) and public health (dietary antioxidants, malaria resistance in G6PD deficiency).

Equations and Key Reactions (LaTeX)

  • Superoxide formation: O<em>2+eO</em>2\text{O}<em>2 + e^- \rightarrow \text{O}</em>2^{\bullet-}.

  • Dismutation of superoxide by SOD: 2O<em>2+2H+H</em>2O<em>2+O</em>22\,\text{O}<em>2^{\bullet-} + 2\,\text{H}^+ \rightarrow \text{H}</em>2\text{O}<em>2 + \text{O}</em>2

  • Fenton reaction: Fe2++H<em>2O</em>2Fe3++OH+OH\text{Fe}^{2+} + \text{H}<em>2\text{O}</em>2 \rightarrow \text{Fe}^{3+} + \text{OH}^- + \text{OH}^{\bullet}.

  • Peroxynitrite formation: NO+O2ONOO\text{NO}^{\bullet} + \text{O}_2^{\bullet-} \rightarrow \text{ONOO}^-.

  • NOS-catalyzed NO production: Arginine+O<em>2+NADPHCitrulline+NO+NADP++H</em>2O\text{Arginine} + \text{O}<em>2 + \text{NADPH} \rightarrow \text{Citrulline} + \text{NO}^{\bullet} + \text{NADP}^+ + \text{H}</em>2\text{O}.

  • GSSG reduction by NADPH: GSSG+NADPH+H+2GSH+NADP+\text{GSSG} + \text{NADPH} + \text{H}^+ \rightarrow 2\text{GSH} + \text{NADP}^+.

  • GPx-catalyzed reduction of extH<em>2extO</em>2ext{H}<em>2 ext{O}</em>2: 2GSH+H<em>2O</em>2GSSG+2H2O2\text{GSH} + \text{H}<em>2\text{O}</em>2 \rightarrow \text{GSSG} + 2\text{H}_2\text{O}.

  • PPP-derived NADPH support: Conceptual role in sustaining GSH/GSSG balance.

Key Takeaways for Exam Preparation

  • Define oxidative stress: Explain ROS/RNS balance and cellular outcomes.

  • List major ROS/RNS: Their interconversions (O<em>2\text{O}<em>2, extO</em>2ext{O}</em>2^{\bullet-}, extH<em>2extO</em>2ext{H}<em>2 ext{O}</em>2, extOHext{OH}^{\bullet}, extNOext{NO}^{\bullet}, extONOOext{ONOO}^-).

  • Describe ETC as ROS source: How ROS are formed inadvertently.

  • Enumerate oxidant sources: Endogenous and exogenous.

  • Explain ROS damage: DNA (8-oxo-dG), proteins (carbonylation), lipids (lipid peroxidation).

  • Outline NOS/NO biology: iNOS/eNOS/nNOS roles and dual nature of NO.

  • Describe GSH/GSSG cycle: Role of GPx, GR, and importance of NADPH/PPP.

  • Explain G6PD deficiency: Inheritance, relevance, clinical consequences, Heinz bodies.

  • Recognize oxygen toxicity: Clinical implications of oxygen therapy.

  • Recall respiratory burst and CGD: Model of defense and infection vulnerability.

  • Understand broad connections: Oxidative stress and diseases (atheroma, cancer, neurodegeneration, aging).